Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using HPV E6/E7-encoding Arenavirus Vaccine HB-201

Review the clinical trials studying hpv e6/e7-encoding arenavirus vaccine hb-201 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-2 of 2

A Vaccine (HB-200) for the Treatment of HPV16 Positive Head and Neck Squamous Cell Cancer with Positive TTMV-HPV DNA after Definitive Treatment
Status: Active
Location: 7 locations
Vaccines (TheraT Vectors) with Carboplatin and Paclitaxel prior to Transoral Robotic Surgery, Radiation Therapy, or Chemoradiation for the Treatment of HPV16 Positive Oropharyngeal Cancer, The TARGET HPV Study
Status: Temporarily Closed to Accrual
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois